Concepedia

Peter Dewland

PD

Statistics

Publications

8

Citations

322

H-Index

8

Active since

1980

Affiliations

3G'S Development Trust(Current)

Peter Dewland is an author at 3G'S Development Trust specializing in clinical pharmacology, pharmacology, and medicine.

Publications per year

1980–2020

8

Publications

8

AICA‐Riboside: Safety, Tolerance, and Pharmacokinetics of a Novel Adenosine‐Regulating Agent

Ross Dixon, James T. Gourzis, Daniel McDermott et al. · The Journal of Clinical Pharmacology · 1991 · 105 citations

Medicine, Pharmacokinetics, Pharmacology +13

Bioavailability of ibuprofen following oral administration of standard ibuprofen, sodium ibuprofen or ibuprofen acid incorporating poloxamer in healthy volunteers

Peter Dewland, Sandie Reader, Philip Berry · BMC Clinical Pharmacology · 2009 · 74 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Absence of a sertraline-mediated effect on the pharmacokinetics and pharmacodynamics of carbamazepine.

Garth Rapeport, Shirley Williams, D C Muirhead et al. · PubMed · 1996 · 43 citations

Medicine, Pharmacokinetics, Pharmacology +10

Clinical evaluation of acetylcysteine in the treatment of patients with chronic obstructive bronchitis: a balanced double-blind trial with placebo control.

Mansel Aylward, J. Maddock, Peter Dewland · PubMed · 1980 · 40 citations

Medicine, Clinical Sciences, Pharmacotherapy +14

Abstract 14387: Dose-Related Reductions in Blood Pressure With a RNA Interference (RNAi) Therapeutic Targeting Angiotensinogen in Hypertensive Patients: Interim Results From a First-In-Human Phase 1 Study of ALN-AGT01

Stephen A. Huang, Jörg Täubel, Giuseppe Fiore et al. · Circulation · 2020 · 21 citations

Medicine, Pharmacology, Pharmacotherapy +17

1–5 of 8